患有心房律失常的患者的护士带领的电气外心转变:系统性审查更新和元分析
Dalia Caleffi1, Luca Pingani2, Sergio Rovesti2
1Clinical and Experimental Medicine PhD Program, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.
Nursing reports (Pavia, Italy)
|February 25, 2025
概括
护士领导的外部直流心脏转换用于心房动是非常成功和安全的,有效率超过80%. 这种方法需要先进的护士培训,其安全性与临床医生主导的程序相美.
科学领域:
- 心脏病学 心脏病学
- 护理实践 护理实践
- 基于证据的医学基于证据的医学.
背景情况:
- 心房动是一种常见的心律不整,需要通过外部心脏转变来控制节律.
- 护士在实施自主干预 (包括心脏转变) 中发挥着关键作用.
- 关于护士主导心脏转变疗效的现有证据需要更新.
研究的目的:
- 系统地审查和更新护士领导的外部直流心脏转变疗法的有效性和安全性的证据.
- 评估成功率,并比较护士主导与临床医生主导的心脏转换的结果.
主要方法:
- 系统审查遵守PRISMA指南的定量研究 (英语/意大利语).
- 搜索了七个数据库;在有效性评估后包括了九篇文章.
- 用几率比率来比较护士带领的DCCV与其他临床医生的三项研究的元分析.
主要成果:
- 在安全条件下,护士领导的直流心脏转换显示出高成功率 (>80%).
- 分析显示,护士主导和临床医生主导的DCCV之间没有显著的风险差异.
- 护士需要高水平的培训;对麻醉和医疗支持缺乏共识.
结论:
- 护士领导的外部直流心脏转换是一种成功和安全的方法,可以恢复鼻节律.
- 有效实施需要先进的护士培训和标准化的协议.
- 需要对患者满意度,成本效益和等待时间进行进一步的研究.
相关概念视频
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Disturbances in Heart Rhythm
860
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
860
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
700
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
700
Electrophysiology of Normal Cardiac Rhythm
1.9K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
1.9K
Mechanism of Cardiac Arrhythmias
872
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
872
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
756
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
756


